The forecast for ischaemic heart disease mortality among Canadian women shows a declining trend from 40.2 in 2024 to 28.2 by 2028 in standardized rates per hundred thousand. Notably, there is a consistent year-on-year decrease, averaging about 8% annually from 2024 to 2028. The compounded annual growth rate (CAGR) over the five-year period indicates a notable decline in deaths by approximately 8% per year, signaling improvements in healthcare management, lifestyle adaptations, or other mitigation strategies.
Future trends to monitor include advancements in medical technology, increased healthcare access, and preventative measures like improved public health campaigns focusing on diet and exercise. Additionally, shifts in demographic patterns, such as aging populations, could impact these forecasts and should be closely watched. Continued research and healthcare investment will play pivotal roles in sustaining this decline.
